Juvenile myoclonic epilepsy masquerading as ecstasy withdrawal

Irish Medical Journal

Volumn 98, Issue 9, 2005, Pages 281-

  Carmondy, J ^a   Delanty, Norman ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CARBAMAZEPINE; ETIRACETAM; FOLIC ACID; PHENYTOIN; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ALCOHOL CONSUMPTION; ARTICLE; CASE REPORT; DRUG WITHDRAWAL; ECCHYMOSIS; ELECTROENCEPHALOGRAM; FALLING; FEMALE; HUMAN; JUVENILE; JUVENILE MYOCLONUS EPILEPSY; MYOCLONUS EPILEPSY; ORBIT DISEASE; PATIENT COMPLIANCE; PATIENT COUNSELING; SLEEP PATTERN; SUBSTANCE ABUSE;

ADOLESCENT; ANTICONVULSANTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HALLUCINOGENS; HUMANS; MYOCLONIC EPILEPSY, JUVENILE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 27944434665     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Devinsky O. Patients with refractory seizures. N Engl J Med 1999;340:1565-70.
2. Janz D. In: Engel J, Pedley TA, eds. Juvenile myoclonic epilepsy in epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven 1997:2389-400.
3. Renganathan R, Delanty N. Juvenile myoclonic epilepsy: under-appreciated and under-diagnosed. Postgrad Med J. 2003 Feb;79:78-80.
4. Faught E. Clinical presentations and phenomenology of myoclonus. Epilepsia 2003;44 Suppl 11:7-12.
5. Bourgeois B. Chronic management of seizures in the syndromes of idiopathic generalised epilepsy. Epilepsia 2003;44 Suppl 2:27-32.
6. Kleveland G, Engelsen BA. Juvenile myoclonic epilepsy: clinical characteristics, treatment and prognosis in a Norwegian population of patients. Seizure 1998;7:31-8.
7. Genton P, Gelisse P, Thomas P, Dravet C. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9.